Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Sarcoma × Mesna × Clear all

Phase

Phase 1 6 Phase 2 4 Phase NA 3 Phase 3 2 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hematologic Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Lymphoma, Non-Hodgkin 4 Hodgkin Disease 4 Breast Neoplasms 4 Lymphoma 3 Leukemia, Myeloid, Acute 3 Neoplasm Metastasis 2 Myelodysplastic Syndromes 2 Multiple Myeloma 2 Leukemia 2 Stomach Neoplasms 1 Sarcoma 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Lymphoma, T-Cell, Cutaneous 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Biphenotypic, Acute 1 Leukemia, B-Cell 1 Inflammatory Breast Neoplasms 1 Hematologic Diseases 1 Graft vs Host Disease 1 Colorectal Neoplasms 1 Burkitt Lymphoma 1 Bronchiolitis Obliterans Syndrome 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Gemcitabine 12 Doxorubicin 11 pembrolizumab 10 Radiotherapy 10 Docetaxel 7 Nivolumab 6 Cyclophosphamide 6 pazopanib 5 Filgrastim 5 Ifosfamide 4 130-nm albumin-bound paclitaxel 4 eribulin 3 Vinorelbine 3 Temozolomide 3 Sirolimus 3 PM 01183 3 Irinotecan 3 Ipilimumab 3 Imatinib Mesylate 3 Drug Therapy 3 Albumin-Bound Paclitaxel 3 talimogene laherparepvec 2 surufatinib 2 selinexor 2 repotrectinib 2 poly ICLC 2 pegfilgrastim 2 liposomal doxorubicin 2 avelumab 2 atezolizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00093509 2014-09-01

MRI Sarcoma Non Invasive Thermometry

Duke University

Phase 1/2 Completed

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡